Національний Медичний Університет Імені О.О. Богомольця
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Національний Медичний Університет Імені О.О. БогомольцяfiledCriticalНаціональний Медичний Університет Імені О.О. Богомольця
Priority to UAU201501680UpriorityCriticalpatent/UA100796U/en
Publication of UA100796UpublicationCriticalpatent/UA100796U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The method for treating the children with the protracted bronchitis and non-severe course of pneumonia comprises provides for the use of the drugs. On the background of basic therapy, Ceftriaxone is administered parenterally at a daily dose of 50-80 mg/kg divided in two doses depending on the severity of the patient's state. On Day 3-4, Cefodox is provided in suspension or in tablets at a daily dose of 10 mg/kg divided in two doses taken with the meals.
UAU201501680U2015-02-262015-02-26Method for treating children with protracted bronchitis and non-severe course of pneumonia
UA100796U
(en)
Clinical contrasts with the American College of Rheumatology/European League Against Rheumatism provisional definitions of remission in rheumatoid arthritis for clinical trials: Comment on the article by Felson et al